Arab World - Prevalence of HIV, female (% ages 15-24)

Prevalence of HIV, female (% ages 15-24) in Arab World was 0.101 as of 2020. Its highest value over the past 30 years was 0.107 in 1999, while its lowest value was 0.100 in 1990.

Definition: Prevalence of HIV, female is the percentage of females who are infected with HIV. Youth rates are as a percentage of the relevant age group.

Source: UNAIDS estimates.

See also:

Year Value
1990 0.100
1991 0.100
1992 0.100
1993 0.101
1994 0.101
1995 0.103
1996 0.104
1997 0.106
1998 0.107
1999 0.107
2000 0.107
2001 0.107
2002 0.106
2003 0.104
2004 0.103
2005 0.102
2006 0.102
2007 0.101
2008 0.101
2009 0.101
2010 0.101
2011 0.101
2012 0.101
2013 0.101
2014 0.101
2015 0.101
2016 0.101
2017 0.101
2018 0.101
2019 0.101
2020 0.101

Limitations and Exceptions: The limited availability of data on health status is a major constraint in assessing the health situation in developing countries. Surveillance data are lacking for many major public health concerns. Estimates of prevalence and incidence are available for some diseases but are often unreliable and incomplete. National health authorities differ widely in capacity and willingness to collect or report information.

Statistical Concept and Methodology: HIV prevalence rates reflect the rate of HIV infection in each country's population. Low national prevalence rates can be misleading, however. They often disguise epidemics that are initially concentrated in certain localities or population groups and threaten to spill over into the wider population. In many developing countries most new infections occur in young adults, with young women especially vulnerable. Data on HIV are from the Joint United Nations Programme on HIV/AIDS (UNAIDS). Changes in procedures and assumptions for estimating the data and better coordination with countries have resulted in improved estimates of HIV and AIDS. The models, which are routinely updated, track the course of HIV epidemics and their impact, making full use of information in HIV prevalence trends from surveillance data as well as survey data. The models take into account reduced infectivity among people receiving antiretroviral therapy (which is having a larger impact on HIV prevalence and allowing HIV-positive people to live longer) and allow for changes in urbanization over time in generalized epidemics. The estimates include plausibility bounds, which reflect the certainty associated with each of the estimates.

Aggregation method: Weighted average

Periodicity: Annual

General Comments: In many developing countries most new infections occur in young adults, with young women especially vulnerable.

Classification

Topic: Health Indicators

Sub-Topic: Risk factors